Is Q5102 still the code to assign for an injection of the biosimilar infliximab?
Code Q5102, which describes both currently available versions of infliximab biosimilars, is the correct code to assign but only until March 31, 2018. It will be discontinued effective for claims with dates of service on or after April 1, 2018 and will be replaced with the two codes below.
|Q5103||Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg|
|Q5104||Injection, infliximab-abda, biosimilar, (renflexis), 10 mg|